Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aldosterone – the key to curing high blood pressure?

10.04.2008
Understanding the role of the hormone aldosterone could provide hope of new therapeutic treatments to millions of people who suffer from high blood pressure.

That’s the conclusion of a large body of research being presented today at the annual Society for Endocrinology BES meeting in Harrogate. Aldosterone plays a key role in regulating blood pressure and can affect how susceptible you are to developing hypertension later in life.

Researchers at the Medical Research Council Blood Pressure Unit at the University of Glasgow, led by Prof John Connell, have studied the way in which aldosterone affects blood pressure regulation. Aldosterone is a hormone that is produced by the adrenal glands. It acts on the kidneys to make sure that salt levels in the blood are kept at a safe level. However, it also has important actions to alter heart and blood vessel function. Too much aldosterone increases the risk of stroke and heart failure.

The group found that in older people, higher levels of aldosterone in the bloodstream are associated with high blood pressure, while in young adults, high aldosterone levels indicate you are more likely to subsequently develop hypertension later in life. Individual aldosterone levels are determined by a number of factors. People born with a low birth weight tend to have higher aldosterone levels when they are older. Another important influence is genetics - some people have variants of a gene that controls aldosterone that works more efficiently than others. This means that throughout life, certain individuals will have higher aldosterone levels and are more prone to developing high blood pressure. This also suggests that in the future, we may be able to predict from an early age which individuals are more likely to develop hypertension. Lifestyle modification and new drug treatments might then be targeted specifically at this group of people.

... more about:
»Heart »aldosterone »hypertension »pressure

Approximately 1 in 4 people in the UK have hypertension. The higher your blood pressure, the greater your risk of suffering from a heart attack or a stroke. Evidence suggests that aldosterone may be a causal factor in 10% of patients with high blood pressure(1).

Researcher Prof John Connell said:
“Aldosterone is a key cardiovascular hormone. The higher the level of aldosterone in your blood, the more likely it is that you will suffer from high blood pressure, which will increase your risk of suffering a heart attack or a stroke.

Through our research, we have discovered some of the factors that predispose you to having higher aldosterone levels. We now need to build up a better understanding of how production of aldosterone throughout life is controlled. This could help us to discover how to prevent blood pressure rising with age and also allow us to target new drug treatments for high blood pressure.”

Jennie Evans | alfa
Further information:
http://www.endocrinology.org
http://www.endocrinology.org/meetings/2008/BES2008/prog/prog.aspx

Further reports about: Heart aldosterone hypertension pressure

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>